Evolución de sunitinib en 1ª línea en CCRm: Esquemas alternativos - page 8

4/2:

Evolución de los efectos adversos

Motzer et al J Clin Oncol 2012

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...43